CVS Health to remove AbbVie rheumatoid arthritis drug Humira from some drug reimbursement lists in April Ruchika Sharma4 Jan 2024 12:30 PM ISTA CVS spokesperson said the company expects most of its customers to transition their coverage to biosimilars of Humira, known chemically as...
AbbVie to focus on smaller deals after buying spree Ruchika Sharma9 Dec 2023 2:30 PM ISTAbbVie said it expects to return to "robust growth" in 2025, after its recent buying spree.
AbbVie to acquire Cerevel Therapeutics for USD 8.7 billion Ruchika Sharma8 Dec 2023 12:30 PM ISTNorth Chicago: AbbVie Inc. and Cerevel Therapeutics have announced a definitive agreement under which AbbVie will acquire Cerevel Therapeutics and its...
Boehringer unveils 81 percent discounted biosimilar of AbbVie Humira Ruchika Sharma4 Oct 2023 3:30 PM ISTUntil recently, Humira was the world's biggest-selling prescription drug. It had sales of USD 21.2 billion in 2022.
AbbVie blood cancer combo therapy fails in late-stage study Ruchika Sharma2 Oct 2023 1:00 PM ISTUnited States: AbbVie has said a late-stage study of its experimental combination therapy to treat a form of blood cancer failed to meaningfully...
AbbVie gets European Commission nod for Aquipta for prophylaxis of migraine in adults Ruchika Sharma20 Aug 2023 3:00 PM ISTNorth Chicago: AbbVie has announced that the European Commission has approved AQUIPTA (atogepant) for the prophylaxis of migraine in adults...
Lupin receives over Rs 205 crore from AbbVie for meeting key product development milestone Ruchika Sharma30 Jun 2023 2:00 PM ISTMumbai: Global pharma major Lupin Limited has announced the achievement of a key milestone for its novel MALT1 (Mucosa-Associated Lymphoid Tissue ...
Coherus resolves part of dispute with AbbVie over Humira biosimilar Ruchika Sharma17 Jun 2023 11:00 AM ISTCoherus BioSciences said on Thursday it had agreed to retract a restraining order against AbbVie as the two fight over the terms of launching a...
AbbVie gets USFDA nod for EPKINLY to treat adult patients with relapsed or refractory Diffuse Large B-Cell Lymphoma Ruchika Sharma20 May 2023 11:30 AM ISTDLBCL is a type of aggressive, fast-growing non-Hodgkin's lymphoma, a cancer that develops in the lymphatic system and affects B cells, a type of...
AbbVie plan to withdraw accelerated nods of Imbruvica in US for patients with certain types of blood cancer Ruchika Sharma7 April 2023 3:30 PM ISTIMBRUVICA is jointly developed and commercialized by Pharmacyclics LLC, an AbbVie company and Janssen Biotech, Inc.
AbbVie trims profit forecasts on IPRnD expenses Ruchika Sharma7 April 2023 2:30 PM ISTUnited States: AbbVie Inc has lowered its full-year and first-quarter profit expectations, citing a $150 million hit from acquired in-process...
USFDA refuses to approve AbbVie Parkinson's disease therapy ABBV-951, seeks more information Ruchika Sharma23 March 2023 12:15 PM ISTThe US health regulator has not sought additional efficacy and safety trials, the company said, adding it plans to resubmit the marketing application...
